Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016)
Anika Therapeutics (ANIK) posted quarterly Construction in Progress of $22.7 million for Q4 2016, up 101.3% year-over-year from $11.3 million in Q1 2016, and up 101.3% quarter-over-quarter from $11.3 million in Q4 2015.
Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016) Analysis & Trends
Anika Therapeutics (ANIK) has reported Construction in Progress for 6 consecutive years, with $22.7 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Construction in Progress rose 101.3% year-over-year to $22.7 million; the TTM figure through Dec 2016 stood at $22.7 million (up 101.3% YoY), while the FY2016 annual figure was $22.7 million, up 101.3% from the prior year.
- Construction in Progress climbed to $22.7 million in Q4 2016 per ANIK's latest filing, from $11.3 million in the prior quarter.
- Across five years, Construction in Progress topped out at $22.7 million in Q4 2016 and bottomed at $42270.0 in Q4 2012.
- Historically, Construction in Progress has averaged $6.9 million across 5 years, with a median of $559000.0 in 2014.
- Annual changes were most pronounced in 2012 — Construction in Progress plunged 99.84% — and 2015, when it jumped 1916.82%.
- Anika Therapeutics' Construction in Progress stood at $42270.0 in 2012, then jumped by 272.11% to $157292.0 in 2013, then soared by 255.39% to $559000.0 in 2014, then surged by 1916.82% to $11.3 million in 2015, then jumped by 101.3% to $22.7 million in 2016.
- Business Quant data shows ANIK's Construction in Progress at $22.7 million in Q4 2016, $11.3 million in Q4 2015, and $559000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Anika Therapeutics | 283.60 Mn | 245.18 Mn | 21.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 22.70 Mn |
| Dec 31, 2015 | 11.27 Mn |
| Dec 31, 2014 | 559,000.00 |
| Dec 31, 2013 | 157,292.00 |
| Dec 31, 2012 | 42,270.00 |
| Dec 31, 2011 | 27.16 Mn |